Puma Biotechnology, Inc. (PBYI) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 142.26M | 162.69M | 143.58M | 136.58M | 132.51M | 147.66M | 156.82M | 137.72M | 143.03M | 156.19M | 125.35M | 118.55M |
| Cash & Short-Term Investments | 101.6M | 97.53M | 94.39M | 96.02M | 93.17M | 100.97M | 96.72M | 96.83M | 107.16M | 95.94M | 85.03M | 74.44M |
| Cash Only | 36.2M | 29.64M | 53.52M | 54.66M | 63.03M | 69.22M | 67.26M | 67.15M | 76.75M | 84.58M | 81.8M | 60.01M |
| Short-Term Investments | 65.4M | 67.89M | 40.86M | 41.36M | 30.14M | 31.75M | 29.46M | 29.68M | 30.41M | 11.35M | 3.23M | 14.43M |
| Accounts Receivable | 26.33M | 53.65M | 33.56M | 25.91M | 25.17M | 32.01M | 54.64M | 28.11M | 24.58M | 48.49M | 28.97M | 31.29M |
| Days Sales Outstanding | 80.31 | 53.17 | 50.22 | 44.33 | 55.93 | 67.47 | 47.26 | 50.92 | 75.97 | 49.37 | 49.4 | 52.08 |
| Inventory | 0 | 5.51M | 9.48M | 8.59M | 8.75M | 8.72M | 2.67M | 9.05M | 7.1M | 7.08M | 5.68M | 7.63M |
| Days Inventory Outstanding | - | 29.82 | 68.27 | 64.15 | 74.5 | 37.66 | 18.53 | 68.94 | 60.14 | 24.13 | 46.09 | 44.21 |
| Other Current Assets | 14.33M | 4M | 4.58M | 3.77M | 3.34M | 3.7M | 2.78M | 2.07M | 2.15M | 260K | 3.41M | 2.01M |
| Total Non-Current Assets | 50.44M | 53.62M | 59.28M | 58.34M | 63.67M | 65.67M | 63.9M | 67.28M | 71.12M | 74.34M | 78.25M | 81.94M |
| Property, Plant & Equipment | 0 | 5.56M | 6.45M | 3.22M | 4.19M | 5.09M | 6.02M | 6.91M | 7.78M | 8.65M | 9.45M | 10.89M |
| Fixed Asset Turnover | - | 12.56x | 11.27x | 14.16x | 9.91x | 10.63x | 12.46x | 6.41x | 5.33x | 7.98x | 5.52x | 4.84x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 38.96M | 41.39M | 43.83M | 46.26M | 48.7M | 51.13M | 53.57M | 56M | 58.44M | 60.87M | 63.3M | 65.74M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 2.09M | 2.09M | 2.09M | 2.09M | 0 | 0 |
| Other Non-Current Assets | 11.48M | 2.83M | 9M | 1.78M | 3.71M | 2.38M | 2.23M | 2.28M | 2.82M | 2.73M | 8.09M | 5.31M |
| Total Assets | 192.7M | 216.3M | 202.86M | 194.92M | 196.18M | 213.33M | 220.72M | 205M | 214.15M | 230.53M | 203.6M | 200.49M |
| Asset Turnover | 0.22x | 0.36x | 0.27x | 0.27x | 0.22x | 0.27x | 0.38x | 0.22x | 0.20x | 0.33x | 0.28x | 0.28x |
| Asset Growth % | -1.77% | 1.39% | -8.09% | -4.92% | -8.39% | -7.46% | 8.41% | 2.25% | 9.12% | 3.81% | 2.43% | 3.53% |
| Total Current Liabilities | 59.74M | 81.25M | 82.73M | 79.1M | 86.66M | 96.11M | 110.4M | 104.3M | 98.19M | 99.38M | 67.36M | 60.29M |
| Accounts Payable | 8.17M | 5.06M | 6.39M | 5.42M | 6.03M | 5.51M | 7.51M | 13.5M | 8.96M | 6.89M | 5.06M | 7.79M |
| Days Payables Outstanding | 57.08 | 22.76 | 44.63 | 42.35 | 49.17 | 43.02 | 33.21 | 95.9 | 67.24 | 22.6 | 44.52 | 62.87 |
| Short-Term Debt | 11.41M | 22.52M | 33.72M | 34M | 45.33M | 45.33M | 45.33M | 45.33M | 45.33M | 34M | 22.66M | 11.33M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.77M | 0 |
| Other Current Liabilities | 40.16M | 16.5M | 14.34M | 12.65M | 9.12M | 15.18M | 52.21M | 32.26M | 32.64M | 43.42M | -8.15M | 9.22M |
| Current Ratio | 2.38x | 2.00x | 1.74x | 1.73x | 1.53x | 1.54x | 1.42x | 1.32x | 1.46x | 1.57x | 1.86x | 1.97x |
| Quick Ratio | 2.38x | 1.93x | 1.62x | 1.62x | 1.43x | 1.45x | 1.40x | 1.23x | 1.38x | 1.50x | 1.78x | 1.84x |
| Cash Conversion Cycle | - | 60.23 | 73.87 | 66.12 | 81.25 | 62.12 | 32.58 | 23.96 | 68.87 | 50.9 | 50.97 | 33.42 |
| Total Non-Current Liabilities | 4.55M | 4.71M | 4.87M | 11.1M | 12.41M | 25.1M | 39.24M | 52.2M | 64.98M | 77.7M | 97.5M | 109.81M |
| Long-Term Debt | 4.55M | 0 | 0 | 10.87M | 10.65M | 21.72M | 32.75M | 43.73M | 54.69M | 65.66M | 76.63M | 87.62M |
| Capital Lease Obligations | 0 | 4.71M | 4.87M | 0 | 0 | 1.49M | 2.95M | 4.36M | 5.74M | 7.03M | 8.3M | 9.52M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 230K | 1.76M | 1.88M | 3.54M | 4.1M | 4.55M | 5.01M | 12.57M | 12.66M |
| Total Liabilities | 64.28M | 85.96M | 87.59M | 90.2M | 99.07M | 121.21M | 149.63M | 156.49M | 163.17M | 177.09M | 164.86M | 170.09M |
| Total Debt | 15.95M | 28.55M | 41.05M | 49.23M | 61.71M | 74.08M | 86.37M | 98.59M | 110.73M | 111.49M | 112.22M | 112.94M |
| Net Debt | -20.25M | -1.09M | -12.47M | -5.43M | -1.32M | 4.86M | 19.11M | 31.44M | 33.98M | 26.91M | 30.42M | 52.93M |
| Debt / Equity | 0.12x | 0.22x | 0.36x | 0.47x | 0.64x | 0.80x | 1.21x | 2.03x | 2.17x | 2.09x | 2.90x | 3.72x |
| Debt / EBITDA | - | 1.44x | 3.34x | 5.24x | 9.10x | 4.57x | 3.46x | 135.24x | 185.18x | 6.30x | 9.79x | 14.54x |
| Net Debt / EBITDA | - | -0.06x | -1.01x | -0.58x | -0.19x | 0.30x | 0.77x | 43.12x | 56.83x | 1.52x | 2.65x | 6.81x |
| Interest Coverage | -5.24x | 16.29x | 7.21x | 4.36x | 2.50x | 5.67x | 7.65x | -0.23x | -0.37x | 4.60x | 2.57x | 1.70x |
| Total Equity | 128.42M | 130.34M | 115.27M | 104.72M | 97.11M | 92.13M | 71.09M | 48.51M | 50.98M | 53.44M | 38.74M | 30.4M |
| Equity Growth % | 32.24% | 41.48% | 62.15% | 115.87% | 90.48% | 72.38% | 83.49% | 59.57% | 97.25% | 147.33% | 74.87% | 54.01% |
| Book Value per Share | 2.53 | 2.53 | 2.26 | 2.09 | 1.95 | 1.86 | 1.45 | 1.00 | 1.06 | 1.11 | 0.81 | 0.64 |
| Total Shareholders' Equity | 128.42M | 130.34M | 115.27M | 104.72M | 97.11M | 92.13M | 71.09M | 48.51M | 50.98M | 53.44M | 38.74M | 30.4M |
| Common Stock | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K |
| Retained Earnings | -1.29B | -1.28B | -1.3B | -1.31B | -1.31B | -1.31B | -1.33B | -1.35B | -1.35B | -1.35B | -1.36B | -1.36B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -31K | 36K | 19K | -14K | -11K | 6K | 26K | -32K | -26K | -4K | -4K | -6K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |